MétaCan
Menu
Back to cohort
Record W7073692750

Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis

2015· article· en· W7073692750 on OpenAlexfundno aff

Bibliographic record

VenueArchive ouverte UNIGE (University of Geneva) · 2015
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
FundersCilagJanssen PharmaceuticalsNational Institute on AgingInstituto de Salud Carlos IIICharles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. LouisCanadian Institutes of Health ResearchNational Institutes of HealthRégion NormandieH. Lundbeck A/SMerz PharmaceuticalsVlaamse regeringIXICOTurun Yliopistollinen KeskussairaalaMedical Research CouncilServierInnovative Medicines InitiativeCenter for Translational Molecular MedicineNational Institute of Biomedical Imaging and BioengineeringRigshospitaletKuopion Yliopistollinen SairaalaAvid RadiopharmaceuticalsUniversity of PittsburghKU LeuvenFoundation for the National Institutes of HealthUniversity of Southern CaliforniaEisaiDeutsche ForschungsgemeinschaftTechnische Universität MünchenInstitut National de la Santé et de la Recherche MédicaleMinistero della SaluteFonds Wetenschappelijk OnderzoekMedpaceBundesministerium für Bildung und ForschungJanssen Research and DevelopmentZonMwKrajowy Naukowy Osrodek WiodacySchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungU.S. Department of DefenseCommonwealth Scientific and Industrial Research OrganisationBayer HealthCareGenentechFondation pour la Recherche sur AlzheimerAstraZenecaEuropean CommissionPfizerEU Joint Programme – Neurodegenerative Disease ResearchUniversiteit AntwerpenNorthern California Institute for Research and EducationNational Research CentreAgence Nationale de la RechercheBiogenBioClinicaUniversity of California, San DiegoCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasSundhed og Sygdom, Det Frie ForskningsrådIndian Council of Medical ResearchLundbeckfondenEli Lilly and CompanyItä-Suomen YliopistoNational Health and Medical Research CouncilEdith Cowan UniversityF. Hoffmann-La RocheSynarcBristol-Myers SquibbEuropean Regional Development FundAcademy of FinlandAlzheimer's Disease Neuroimaging InitiativeMeso Scale DiagnosticsAlzheimer's AssociationEuropean Federation of Pharmaceutical Industries and AssociationsScience and Industry Endowment FundDementia Collaborative Research Centres, AustraliaBelgian Federal Science Policy OfficeNational Science Foundation
KeywordsDementiaPathologicalAmyloid (mycology)Apolipoprotein EDiseaseCognitionCognitive impairmentAlzheimer's diseaseBiomarker
DOInot available

Abstract

fetched live from OpenAlex

Cerebral amyloid-β aggregation is an early pathological event in Alzheimer disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid pathology in persons without dementia are needed to understand the development of AD and to design prevention studies.To use individual participant data meta-analysis to estimate the prevalence of amyloid pathology as measured with biomarkers in participants with normal cognition, subjective cognitive impairment (SCI), or mild cognitive impairment (MCI).Relevant biomarker studies identified by searching studies published before April 2015 using the MEDLINE and Web of Science databases and through personal communication with investigators.Studies were included if they provided individual participant data for participants without dementia and used an a priori defined cutoff for amyloid positivity.Individual records were provided for 2914 participants with normal cognition, 697 with SCI, and 3972 with MCI aged 18 to 100 years from 55 studies.Prevalence of amyloid pathology on positron emission tomography or in cerebrospinal fluid according to AD risk factors (age, apolipoprotein E [APOE] genotype, sex, and education) estimated by generalized estimating equations.The prevalence of amyloid pathology increased from age 50 to 90 years from 10% (95% CI, 8%-13%) to 44% (95% CI, 37%-51%) among participants with normal cognition; from 12% (95% CI, 8%-18%) to 43% (95% CI, 32%-55%) among patients with SCI; and from 27% (95% CI, 23%-32%) to 71% (95% CI, 66%-76%) among patients with MCI. APOE-ε4 carriers had 2 to 3 times higher prevalence estimates than noncarriers. The age at which 15% of the participants with normal cognition were amyloid positive was approximately 40 years for APOE ε4ε4 carriers, 50 years for ε2ε4 carriers, 55 years for ε3ε4 carriers, 65 years for ε3ε3 carriers, and 95 years for ε2ε3 carriers. Amyloid positivity was more common in highly educated participants but not associated with sex or biomarker modality.Among persons without dementia, the prevalence of cerebral amyloid pathology as determined by positron emission tomography or cerebrospinal fluid findings was associated with age, APOE genotype, and presence of cognitive impairment. These findings suggest a 20- to 30-year interval between first development of amyloid positivity and onset of dementia.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.065
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.051
GPT teacher head0.277
Teacher spread0.226 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations98
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueArchive ouverte UNIGE (University of Geneva)Same topicDementia and Cognitive Impairment ResearchFrench-language works237,207